Skip to content

ARS Pharmaceuticals, Inc. SPRY Investment Purchases

Investment Purchases at other companies

Travel + Leisure logo
Travel + LeisureTNL
$8M
Unifirst logo
UnifirstUNF
$5.66M
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$177.41M+85.8%
Alignment Healthcare logo
Alignment HealthcareALHC
$10.6M-40.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$238.59M+254%
GitLab logo
GitLabGTLB
$222.2M-9.7%

Other financials

Income statement

See full
Revenue$22.7M+184%
Operating income-$60.1M-61.8%
Net income-$60.6M-78.6%
EPS (diluted)-$0.61-74.3%

Balance sheet

See full
Cash & equivalents$24.3M-39.0%
Total debt$96.5M+132,122%
Total equity$61.3M-73.2%
Total assets$287.6M-12.1%

Cash flow

See full
Operating cash flow-$44.9M-10.3%
CapEx--100%
Free cash flow-$44.9M-10.1%

Valuation

See full
Market cap$796.41M-48.7%
Enterprise value$868.61M-42.6%
P/S8.1×-7.9×

Profitability

See full
Operating margin-204.5%
Net margin-200%-219pp
FCF margin-177.1%-206pp

Returns & leverage

See full
Return on equity-136.4%-144pp
Debt / equity1.6×+1.6×
Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s investment purchases?
ARS Pharmaceuticals, Inc. (SPRY) reported investment purchases of $14.71M in Q1 2026.
How has ARS Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
ARS Pharmaceuticals, Inc.'s investment purchases decreased by 57.2% year-over-year, from $34.35M to $14.71M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.